Hyperthermy Endocavitary Treatment in Pelvic Pain
Endocavitary Radiofrequency Treatment in Patients Who Present With Chronic Pelvic Pain Compared to Usual Drug Therapy
1 other identifier
interventional
60
1 country
1
Brief Summary
- Treatment at pelvic floor with hyperactivity with hyperthermy electrode MJS
- MJS electrode is effective for transvaginal treatment at pelvic pain patients
- Hyperthermy treatment with MJS electrode is more effective to usual drugs treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 6, 2016
CompletedFirst Posted
Study publicly available on registry
July 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedDecember 5, 2016
December 1, 2016
1.3 years
July 6, 2016
December 2, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
NIH-CPSI questionnaire
questions for pelvic pain evaluation
four weeks
Secondary Outcomes (1)
pain measure questionnaire
four weeks
Study Arms (2)
Hyperthermy treatment with MJS electrode
ACTIVE COMPARATOR30 patients who are diagnosed with myofascial syndrome by gyneacologist or urologist goes to Pelvic Floor Physiotherapist for 4 session with hyperthermy treatment with MJS electrode at pelvic floor trigger points
CONTROL
NO INTERVENTIONNo intervention with radiofrequency treatment, only evaluation to usual drug treatment
Interventions
30 patients who are diagnosed Pelvic pain with myofascial syndrome by gyneacologist or urologist goes to Pelvic Floor Physiotherapist for 4 session with hyperthermy treatment with MJS electrode at pelvic floor trigger points
Eligibility Criteria
You may qualify if:
- Women with chronic pelvic pain
You may not qualify if:
- chronic pelvic pain or neurological degenerative etiology
- Presence of pathology or infectious processes genitourinary level
- possibility of pregnancy or lactating.
- Lack of informed consent, mental disorders, dementia, dependent people who need tutor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marta Sainz
Málaga, Málaga, 29018, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Carolina Walker, Dr
Universitat Central de Catalunya
- STUDY DIRECTOR
Marta Losa, Dr
Universidad Rey Juan Carlos
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, coordinator of Pelvic floor department, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
July 6, 2016
First Posted
July 19, 2016
Study Start
August 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
December 5, 2016
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will share
It's approved from 2015 May to 2016 December, when the investigators have to report clinical trial conclusions